JAVELIN PHARMACEUTICALS, INC (JAV) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 86 transactions totaling $4.0M, demonstrating a bullish sentiment with $2.4M in net insider flow. The most recent transaction on Jul 2, 2010 involved a transaction of 12,500 shares valued at $27.5K.
No significant insider buying has been recorded for JAV in the recent period.
No significant insider selling has been recorded for JAV in the recent period.
Based on recent SEC filings, insider sentiment for JAV is bullish with an Insider Alignment Score of 80/100 and a net flow of $2.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at JAVELIN PHARMACEUTICALS, INC (JAV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading JAV stock, having executed 86 transactions in the past 90 days. The most active insider is Peter D. Kiernan III (Executive), who has made 45 transactions totaling $5.8M.
Get notified when executives and directors at JAV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 2, 2010 | J. Tulipano Stephen | Executive | Disposition | 12,500 | $2.20 | $27.5K | |
| Jul 2, 2010 | J. Driscoll Martin | Executive | Disposition | 59,524 | $2.20 | $131.0K | |
| Jul 2, 2010 | J. Driscoll Martin | Executive | Disposition | 179,529 | $2.20 | $395.0K | |
| Jul 2, 2010 | Flanzraich Neil | Executive | Disposition | 1,000,000 | $2.20 | $2.2M | Large |
| Jul 2, 2010 | B. Carr Daniel | Executive | Disposition | 59,524 | $2.20 | $131.0K | |
| Jul 2, 2010 | D. Kiernan Peter III | Executive | Disposition | 2,411,848 | $2.20 | $5.3M | Large |
| Jun 30, 2010 | J. Tulipano Stephen | Executive | Tender | 10,115 | $2.20 | $22.3K | |
| Jun 30, 2010 | G. Watson Douglas | Executive | Tender | 20,000 | $2.20 | $44.0K | |
| Jun 30, 2010 | H. Mermelstein Fred | Executive | Tender | 577,316 | $2.20 | $1.3M | Large |
| Jun 30, 2010 | B. Carr Daniel | Executive | Tender | 80,494 | $2.20 | $177.1K | |
| May 3, 2010 | B. Carr Daniel | Executive | Sale | 18,450 | $2.18 | $40.2K | |
| May 3, 2010 | J. Tulipano Stephen | Executive | Sale | 2,385 | $2.18 | $5.2K | |
| Mar 26, 2010 | B. Carr Daniel | Executive | Sale | 700 | $1.35 | $945 | |
| Mar 26, 2010 | B. Carr Daniel | Executive | Option Exercise | 767 | $1.07 | $821 | |
| Mar 25, 2010 | B. Carr Daniel | Executive | Option Exercise | 5,307 | $1.07 | $5.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 6 | $8.2M | 58.1% |
Purchase(P) | 58 | $3.2M | 22.9% |
Tender(U) | 4 | $1.5M | 10.7% |
Sale(S) | 5 | $784.2K | 5.6% |
Exercise (Options)(X) | 2 | $350.0K | 2.5% |
Exercise(M) | 3 | $36.7K | 0.3% |
Award(A) | 7 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at JAVELIN PHARMACEUTICALS, INC are accumulating shares at an accelerated pace. With 11 insiders making 86 transactions totaling $3.2M in purchases versus $784.2K in sales, the net buying activity of $2.4M signals strong executive confidence. Peter D. Kiernan III (Executive) leads the buying activity with $5.8M in transactions across all time.